Latest News and Press Releases
Want to stay updated on the latest news?
-
ATLANTA, May 14, 2020 (GLOBE NEWSWIRE) -- American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) (“AVCT”) announces the addition of Dominick Passanante as Chief Revenue Officer to its executive...
-
Talicia® is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. pylori bacteria to standard-of-care...
-
MIAMI, April 18, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in...
-
San Diego, CA, March 05, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces its Breast Cancer Index (BCI) test has been issued a new Medicare Local Coverage Determination [(LCD) L37822] by...
-
MIAMI, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in CBS...
-
Norcross, GA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- EasyCare announced the launch of a suite of Rideshare benefits that includes Rideshare VSC, Rideshare GAP and Rideshare Prepaid Maintenance. These new...
-
MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that Chief Executive Officer S. Parikh Mars...
-
Waltham, MA, May 09, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. has continued to make significant progress in expanding contracts to provide laboratory services and ExoDx®...
-
Los Angelese, March 22, 2018 (GLOBE NEWSWIRE) -- Beazley, a leading insurer of manufacturers and distributors of nutraceutical products, has broadened coverage under its NutraGuard policy to address...
-
WINNIPEG, Manitoba, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Manitoba Lobby Day 2017 is an opportunity to make a difference. Today, 10 T1D Heroes – advocates living with type 1 diabetes (T1D) – are at the...